BioAge Labs scraps Phase 2 obesity trial just months after IPOnews2024-12-06T22:32:41+00:00December 6th, 2024|Endpoints News|
Insurance executive killing puts spotlight on security measures at JP Morgan meetingnews2024-12-06T19:58:01+00:00December 6th, 2024|Endpoints News|
European Commission greenlights $16.5B Novo-Catalent acquisition news2024-12-06T18:32:53+00:00December 6th, 2024|Endpoints News|
Novartis bolsters Fabhalta data in competition with AstraZenecanews2024-12-06T17:45:30+00:00December 6th, 2024|Endpoints News|
National Resilience to cut 105 employees at Florida site as new CEO takes overnews2024-12-06T16:16:09+00:00December 6th, 2024|Endpoints News|
Teva to divest business venture in Japan; Layoffs at Rome Therapeutics news2024-12-06T15:34:11+00:00December 6th, 2024|Endpoints News|
UK’s local vaccine production stymied by budget cuts, government committee saysnews2024-12-06T12:30:04+00:00December 6th, 2024|Endpoints News|
AstraZeneca and Daiichi report pooled ADC data in mutant lung cancernews2024-12-06T12:10:04+00:00December 6th, 2024|Endpoints News|
Mark Alles’ ADC bet TORL poaches J&J medical exec; Samsung Bioepis makes historic CEO appointmentnews2024-12-06T12:00:34+00:00December 6th, 2024|Endpoints News|
BioNTech, DualityBio report promising ADC data in solid tumorsnews2024-12-06T11:41:05+00:00December 6th, 2024|Endpoints News|
